- Q1 2024 Delcath Systems Inc Earnings Call TranscriptMay 14, 2024$7.07 (+30.93%)Earnings
- Q4 2023 Delcath Systems Inc Earnings Call TranscriptMar 26, 2024$4.61 (-1.07%)Earnings
- Q3 2023 Delcath Systems Inc Earnings Call TranscriptNov 13, 2023$2.98 (+1.02%)Earnings
- Delcath Systems Inc at Lytham Partners Fall Investor Conference TranscriptOct 17, 2023
- Delcath Systems Inc Annual Shareholders Meeting TranscriptJun 12, 2023
- Delcath Systems Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Q1 2023 Delcath Systems Inc Earnings Call TranscriptMay 12, 2023$6 (-0.75%)Earnings
- Q3 2022 Delcath Systems Inc Earnings Call TranscriptNov 08, 2022$2.79 (-7.00%)Earnings
- Delcath Systems Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Q1 2022 Delcath Systems Inc Earnings Call TranscriptMay 10, 2022$5.3 (-8.62%)Earnings
- Delcath Systems Inc Annual Shareholders Meeting TranscriptMay 04, 2022
- Delcath Systems Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptApr 04, 2022
- Q4 2021 Delcath Systems Inc Earnings Call TranscriptMar 25, 2022$6.19 (-2.06%)Earnings
- Q3 2021 Delcath Systems Inc Earnings Call TranscriptNov 09, 2021$11.42 (+2.42%)Earnings
- Q3 2020 Delcath Systems Inc Earnings Call TranscriptNov 11, 2020$11.51Earnings
- Delcath Systems Inc Call with Dr. Jonathan Zager, Principal Investigator for Delcath's Ph3 FOCUS Study TranscriptSep 30, 2020
- Q2 2020 Delcath Systems Inc Earnings Call TranscriptAug 13, 2020$12.4 (-2.82%)Earnings
Delcath Systems Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
Hello, everyone, and welcome to the Lytham Partners Spring 2023 Investor Conference. My name is Ben Shamsian, Vice President of Lytham Partners. Thank you for joining us today for our oncology panel titled, advancements in the fight against cancer.
We are joined today by two executives from two great companies from the industry to get some insights on how they see this space. I've gathered some topics of interest to investors and hope to learn greatly from our panelists.
Joining us today are Gerard Michel, CEO of Delcath Technologies (sic - Delcath Systems), ticker DCTH on the Nasdaq; as well as Dr. Anatoly Dritschilo, CEO of Shuttle Pharmaceuticals, ticker SHPH. I want to remind everyone that our management teams are available for one-on-one meetings. (Operator Instructions)
Before we begin with the discussion, I would like to have each of you introduce yourselves and provide a five-minute background on your companies. Gerard, we can start with you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)